FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200017988> ?p ?o ?g. }

• W4200017988 endingPage "3691" @default.
• W4200017988 startingPage "3683" @default.
• W4200017988 abstract "The aims of this paper were to determine the effect of virgin coconut oil (VCO) on bodyweight and serum glucose level among acute coronary syndrome (ACS) patients. Various clinical trials on animal studies have found that the VCO has many beneficial effects on health. However, there have been limited published human studies on the pharmacological properties of VCO. Investigation on human subjects is extremely required in order to provide more empirical evidence to show the effect of VCO for ACS patients. Randomised single blind study conducted between March 2018 and April 2018. RCT was conducted among 70 ACS patients for 30 days. Participants in group A received their bottles containing 100 pieces of virgin coconut oil soft gels and were required to ingest 10 capsules per day (5 mL/5 gm) and continue routine treatment (diabetic diet and diabetic medication). Group B participants continued receiving routine treatment. Changes in serum fating blood sugar and body weight were identified using a paired t-test and independent t-test. A total of 70 patients participated with ages of 51 years old and older and were mostly male. The serum FBS and body weight of the intervention group that received VCO were reduced about 13.6% on day 30, from the baseline on day 1. They also had body weight reduction of about 2% with p value of less than 0.05. In contrast, the control group that only received routine treatment showed an increment of 12.1% in their serum FBS and had no changes in body weight. These reductions were noted within 30 days of consuming a daily dose of VCO (5 g every day). The properties of lauric acid and antioxidants present in the VCO composition were key players in the reduction of serum glucose levels and body weight. VCO can reduce serum glucose levels and body weight with 5 mL (5 g) of VCO per day for 30 days. Also, VCO may have a positive effect towards the glucose level and other cardiovascular risk factors." @default.
• W4200017988 created "2021-12-31" @default.
• W4200017988 creator A5032949050 @default.
• W4200017988 creator A5034564721 @default.
• W4200017988 creator A5048776312 @default.
• W4200017988 creator A5068561401 @default.
• W4200017988 creator A5069349533 @default.
• W4200017988 date "2021-12-31" @default.
• W4200017988 modified "2023-09-26" @default.
• W4200017988 title "A Randomized Controlled Trial on the Effect of VCO in Reducing Glucose and Body Weight in Post-Acute Coronary Syndrome Patients: A Pilot Study" @default.
• W4200017988 doi "https://doi.org/10.17576/jsm-2021-5012-18" @default.
• W4200017988 hasPublicationYear "2021" @default.
• W4200017988 type Work @default.
• W4200017988 citedByCount "0" @default.
• W4200017988 crossrefType "journal-article" @default.
• W4200017988 hasAuthorship W4200017988A5032949050 @default.
• W4200017988 hasAuthorship W4200017988A5034564721 @default.
• W4200017988 hasAuthorship W4200017988A5048776312 @default.
• W4200017988 hasAuthorship W4200017988A5068561401 @default.
• W4200017988 hasAuthorship W4200017988A5069349533 @default.
• W4200017988 hasBestOaLocation W42000179881 @default.
• W4200017988 hasConcept C126322002 @default.
• W4200017988 hasConcept C134018914 @default.
• W4200017988 hasConcept C142724271 @default.
• W4200017988 hasConcept C147583825 @default.
• W4200017988 hasConcept C168563851 @default.
• W4200017988 hasConcept C2777996180 @default.
• W4200017988 hasConcept C2780485761 @default.
• W4200017988 hasConcept C511355011 @default.
• W4200017988 hasConcept C535046627 @default.
• W4200017988 hasConcept C544821477 @default.
• W4200017988 hasConcept C555293320 @default.
• W4200017988 hasConcept C71924100 @default.
• W4200017988 hasConceptScore W4200017988C126322002 @default.
• W4200017988 hasConceptScore W4200017988C134018914 @default.
• W4200017988 hasConceptScore W4200017988C142724271 @default.
• W4200017988 hasConceptScore W4200017988C147583825 @default.
• W4200017988 hasConceptScore W4200017988C168563851 @default.
• W4200017988 hasConceptScore W4200017988C2777996180 @default.
• W4200017988 hasConceptScore W4200017988C2780485761 @default.
• W4200017988 hasConceptScore W4200017988C511355011 @default.
• W4200017988 hasConceptScore W4200017988C535046627 @default.
• W4200017988 hasConceptScore W4200017988C544821477 @default.
• W4200017988 hasConceptScore W4200017988C555293320 @default.
• W4200017988 hasConceptScore W4200017988C71924100 @default.
• W4200017988 hasIssue "12" @default.
• W4200017988 hasLocation W42000179881 @default.
• W4200017988 hasLocation W42000179882 @default.
• W4200017988 hasOpenAccess W4200017988 @default.
• W4200017988 hasPrimaryLocation W42000179881 @default.
• W4200017988 hasRelatedWork W1946491572 @default.
• W4200017988 hasRelatedWork W2032137442 @default.
• W4200017988 hasRelatedWork W2062547047 @default.
• W4200017988 hasRelatedWork W2296239503 @default.
• W4200017988 hasRelatedWork W2358233588 @default.
• W4200017988 hasRelatedWork W2419614677 @default.
• W4200017988 hasRelatedWork W2530217299 @default.
• W4200017988 hasRelatedWork W2736881861 @default.
• W4200017988 hasRelatedWork W2770569791 @default.
• W4200017988 hasRelatedWork W3212384033 @default.
• W4200017988 hasVolume "50" @default.
• W4200017988 isParatext "false" @default.
• W4200017988 isRetracted "false" @default.
• W4200017988 workType "article" @default.